Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FQY53
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,472
Award facts
- Contract value 100% obligated
- $16,471.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,471.83 to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Otezla 30 mg tablets (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by June 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Otezla is a pharmaceutical treatment commonly used for psoriasis, psoriatic arthritis, and other immunological conditions, reflecting the company's role as a critical pharmaceutical supplier to federal military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this contract structure, AmerisourceBergen serves multiple federal healthcare customers including the Defense Health Agency and U.S. Coast Guard, positioning itself as a key vendor in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FQY53?
SPE2DB25FQY53 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 4, 2025.
How much is contract SPE2DB25FQY53 worth?
The government has obligated $16,472 on SPE2DB25FQY53.
Is contract SPE2DB25FQY53 an order under another contract?
Yes. SPE2DB25FQY53 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQY53 competed?
The extent of competition for SPE2DB25FQY53 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award